Advertisement

Acta Endoscopica

, 32:474 | Cite as

Circulaire no DGS/5C/DHOS/E2/2001/138 du 14 mars 2001 relative aux précautions à observer lors de soins en vue de réduire les risques de transmission d’agents transmissibles non conventionnels

  • Elisabeth Guigou
  • Bernard Kouchiner
La Désinfection du Matériel Endoscopique

Résumé

la présente circulaire a pour objet d’acutualiser les recommandations visant à réduire les risques de transmission d’agents transmissibles non conventionnels de lacirculaire DGS/DH no 100 du 11 décembre 1995.

Mots-clés

agents transmissibles non conventionnels et conventionnels désinfection dispositifs médicaux encéphalopathie subaiguë spongiforme transmissible infection nosocomiale inactivation maladie de Creutfeldt-Jakob nouveau variant stérilisation 

Référence

  1. BROWN P., Rohwer R.G., GAJDUSEK D.C. — Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease in brain tissue.J. Infect. Disease, 1986,153, 1145–1148.Google Scholar
  2. WILL R.G., IRONSIDE J.W., ZEIDLER M., COUSENS S.N., ESTIBEIRO K., ALPÉROVITCH A.et al. — A new variant of Creutzfeldt-Jakob disease in the UK.Lancet, 1996,347, 921–925.PubMedCrossRefGoogle Scholar
  3. CHAZOT G., BROUSSOLE E., BLATTIER T., AGUZZI A., KOPP N. — New variant of Creutzfeldt-Jakob disease in a 26-year old French man.Lancet, 1996,347, 1181.PubMedCrossRefGoogle Scholar
  4. RUTALA W. — APIC guideline for selection and use of disinfectants.Am. J. Infect. Control & Steriliz Technol., 1996,24, 313–336.CrossRefGoogle Scholar
  5. BRUCE M.E., WILL R.G., IRONSIDE J.W., M.C. CONNELL I., DRUMMOND D., SUTTIE A.,et al. — Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent.Nature, 1997,389, 498–501.PubMedCrossRefGoogle Scholar
  6. HILTON D.A., FATHERS E., EDWARDS P., IRONSIDE J.W., ZAJICEK J. — Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease.Lancet, 1998,352, 703–704.PubMedCrossRefGoogle Scholar
  7. DARBORD J.C. — Inactivation of prions in daily medical practice.Biomed & Pharmacother, 1999,53, 34–38.CrossRefGoogle Scholar
  8. INGROSSO L., PISANI F., POCCHIARI M. — Transmission of the 263K scrapie strain by the dental route.Journal of General Virology, 1999,80, 3043–3047.PubMedGoogle Scholar
  9. SCOTT M., WILL R., IRONSIDE J., NAUYEN H.O.B., TREMBLAY P., DEARMOND S.et al. — Compelling transgenic evidence for transmission of bovine spongiform encephalopathy prions to humans.Proc. Natl. Acad Sci. USA, 1999,96, 15137–15142.PubMedCrossRefGoogle Scholar
  10. HILL A.F. BUTTERWORTH R.J., JOINER S., JACKSON G., ROSSOR M.N., THOMAS D.J.et al. — Investigation of variant Creutzfeldt-Jakob disease and other prion diseases with tonsil biopsy samples.Lancet, 1999,353, 183–189.PubMedCrossRefGoogle Scholar
  11. TAYLOR D.M. — Inactivation of prions by physical and chemical means.Journal of Hospital Infection, 1999,43, S69-S76.PubMedCrossRefGoogle Scholar
  12. GILL N. — Developments in variant Creutzfeldt-Jakob disease.Eurosurveillance, 2000,5, 89–90.PubMedGoogle Scholar
  13. GHANI A.C., FERGUSON N.M., DONNELLY C.A., ANDERSON R.M. — Predicted vCJD mortality in Great Britain.Nature, 2000,406, 583–584.PubMedCrossRefGoogle Scholar
  14. DORRNONT D. — Le nouveau variant de la maladie de Creutzfeldt-Jakob.Eurosurveillance, 2000,5, 95–97.Google Scholar
  15. HOUSTON F., FOSTER J.D., CHONG A., HUNTER N., BOSTOCK C.J. — Transmission of BSE by blood transfusion in sheep.Lancet, 2000,356, 999–1000.PubMedCrossRefGoogle Scholar
  16. BLANDQUET-GROSSARD F., SAZDOVITCH V., JEAN A., DESLYS J.P., DORMONT D., HAUW J.J., MARION D., BROWN P., CESBRON J.Y. — Prion protein is not detectable in dental pulp from patients with Creutzfeldt-Jakob disease.J. Dent. Res., 2000,79 (2), 700.CrossRefGoogle Scholar
  17. ANDREWS N.J., FARRINGTON C.P., COUSENS S.N., SMITH P.G., WARD H., KNIGHT R.S.G., IRONSIDE J.W., WILL R.G. — Incidence of variant Creut7ièldt-Jakob disease in the UK.Lancet, 2000,356, 481–482.PubMedCrossRefGoogle Scholar
  18. BROWN P., PREECE M., BRANDEL J.P., SATO T., MCSHANE L., ZERR I, FLETCHER A., WILL R.G., POCCHIARI M., CASHINAN N.R., D’AIGNAUX J.H., CERVENAKOVA L., FRADKIN J., SCHONBERGER L.B., COLLINS S.J. — Iatrogenic Creutzfeldt-Jakob disease at the millenium.Neurology, 2000,55 (8), 1075–1081.PubMedGoogle Scholar
  19. TAYLOR D.M. — Inactivation of transmissible degenerative encephalopathy agents: a review.V.et J., 2000,159, 10–17.CrossRefGoogle Scholar
  20. ANTLOGA K., MESZAROS J., MALCHESKY P.S., MCDONNELL G.E. — Prion disease and medical devices.ASAIO J, 2000,46, 69–72.CrossRefGoogle Scholar
  21. Avis et rapports du CSHPF, du CTIN et du CIESST sur la sécurité des endoscopes (Rapports du 30 septembre et du 18 octobre 1999 du groupe de travail tripartite CSHPF-CTIN-CIESST: avis du CIESST du 22 décembre 1999; avis du CIESST du 24 décembre 2000). L’ensemble de ces documents est consultable sur le site Internet du ministère http: //www.sante.gouv.fr.Google Scholar
  22. WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies. Report of a WHO Consultation, Geneva, Switzerland, 23–26 March 1999. Ce document est consultable sur le site Internet de l’OMS http://www.who.ch.Google Scholar

Copyright information

© Springer-Verlag 2002

Authors and Affiliations

  • Elisabeth Guigou
  • Bernard Kouchiner

There are no affiliations available

Personalised recommendations